For example, SYK is activated gradually during the progression of alcoholic or viral liver diseases, and therapeutically blocking SYK function by different chemical inhibitors significantly diminished alcohol-induced hepatic steatosis and viral hepatitis [7, 41, 43]. This evidence concerns the gene SYK and Hepatic steatosis.